iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
132.97
-2.34 (-1.73%)
Mar 25, 2025, 4:00 PM EST - Market closed
IBB Holdings List
As of Mar 21, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | VRTX | Vertex Pharmaceuticals Incorporated | 8.58% |
2 | AMGN | Amgen Inc. | 8.39% |
3 | GILD | Gilead Sciences, Inc. | 7.66% |
4 | REGN | Regeneron Pharmaceuticals, Inc. | 7.38% |
5 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.73% |
6 | IQV | IQVIA Holdings Inc. | 3.45% |
7 | ARGX | argenx SE | 2.76% |
8 | MTD | Mettler-Toledo International Inc. | 2.63% |
9 | WAT | Waters Corporation | 2.30% |
10 | BIIB | Biogen Inc. | 2.18% |
11 | NTRA | Natera, Inc. | 2.05% |
12 | BNTX | BioNTech SE | 1.66% |
13 | INSM | Insmed Incorporated | 1.50% |
14 | ONC | BeiGene, Ltd. | 1.47% |
15 | ILMN | Illumina, Inc. | 1.47% |
16 | UTHR | United Therapeutics Corporation | 1.47% |
17 | BMRN | BioMarin Pharmaceutical Inc. | 1.43% |
18 | ITCI | Intra-Cellular Therapies, Inc. | 1.39% |
19 | INCY | Incyte Corporation | 1.26% |
20 | MRNA | Moderna, Inc. | 1.19% |
21 | NBIX | Neurocrine Biosciences, Inc. | 1.15% |
22 | EXEL | Exelixis, Inc. | 1.07% |
23 | TECH | Bio-Techne Corporation | 1.01% |
24 | PCVX | Vaxcyte, Inc. | 0.99% |
25 | GMAB | Genmab A/S | 0.97% |
26 | CRL | Charles River Laboratories International, Inc. | 0.90% |
27 | MEDP | Medpace Holdings, Inc. | 0.86% |
28 | HALO | Halozyme Therapeutics, Inc. | 0.84% |
29 | RGEN | Repligen Corporation | 0.79% |
30 | ASND | Ascendis Pharma A/S | 0.74% |
31 | SRPT | Sarepta Therapeutics, Inc. | 0.71% |
32 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.68% |
33 | RVMD | Revolution Medicines, Inc. | 0.65% |
34 | BPMC | Blueprint Medicines Corporation | 0.59% |
35 | ALKS | Alkermes plc | 0.58% |
36 | CYTK | Cytokinetics, Incorporated | 0.56% |
37 | BBIO | BridgeBio Pharma, Inc. | 0.55% |
38 | IONS | Ionis Pharmaceuticals, Inc. | 0.54% |
39 | AXSM | Axsome Therapeutics, Inc. | 0.54% |
40 | ROIV | Roivant Sciences Ltd. | 0.51% |
41 | LEGN | Legend Biotech Corporation | 0.50% |
42 | KRYS | Krystal Biotech, Inc. | 0.49% |
43 | BRKR | Bruker Corporation | 0.49% |
44 | ADMA | ADMA Biologics, Inc. | 0.48% |
45 | PTCT | PTC Therapeutics, Inc. | 0.47% |
46 | SWTX | SpringWorks Therapeutics, Inc. | 0.37% |
47 | NUVL | Nuvalent, Inc. | 0.37% |
48 | RNA | Avidity Biosciences, Inc. | 0.36% |
49 | VRNA | Verona Pharma plc | 0.36% |
50 | RARE | Ultragenyx Pharmaceutical Inc. | 0.36% |
51 | CRSP | CRISPR Therapeutics AG | 0.36% |
52 | TEM | Tempus AI, Inc. | 0.33% |
53 | PTGX | Protagonist Therapeutics, Inc. | 0.32% |
54 | AKRO | Akero Therapeutics, Inc. | 0.32% |
55 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.32% |
56 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.31% |
57 | MRUS | Merus N.V. | 0.31% |
58 | ACLX | Arcellx, Inc. | 0.30% |
59 | ACAD | ACADIA Pharmaceuticals Inc. | 0.30% |
60 | FOLD | Amicus Therapeutics, Inc. | 0.28% |
61 | ZLAB | Zai Lab Limited | 0.28% |
62 | XENE | Xenon Pharmaceuticals Inc. | 0.28% |
63 | BHVN | Biohaven Ltd. | 0.27% |
64 | APLS | Apellis Pharmaceuticals, Inc. | 0.27% |
65 | VCYT | Veracyte, Inc. | 0.26% |
66 | TWST | Twist Bioscience Corporation | 0.26% |
67 | SRRK | Scholar Rock Holding Corporation | 0.26% |
68 | VCEL | Vericel Corporation | 0.24% |
69 | SMMT | Summit Therapeutics Inc. | 0.24% |
70 | RXRX | Recursion Pharmaceuticals, Inc. | 0.21% |
71 | NVCR | NovoCure Limited | 0.20% |
72 | MIRM | Mirum Pharmaceuticals, Inc. | 0.19% |
73 | DNLI | Denali Therapeutics Inc. | 0.19% |
74 | TVTX | Travere Therapeutics, Inc. | 0.19% |
75 | ARQT | Arcutis Biotherapeutics, Inc. | 0.19% |
76 | KYMR | Kymera Therapeutics, Inc. | 0.19% |
77 | AGIO | Agios Pharmaceuticals, Inc. | 0.18% |
78 | BEAM | Beam Therapeutics Inc. | 0.18% |
79 | TARS | Tarsus Pharmaceuticals, Inc. | 0.18% |
80 | DVAX | Dynavax Technologies Corporation | 0.17% |
81 | n/a | USD CASH | 0.17% |
82 | EWTX | Edgewise Therapeutics, Inc. | 0.17% |
83 | BCRX | BioCryst Pharmaceuticals, Inc. | 0.17% |
84 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.17% |
85 | MNKD | MannKind Corporation | 0.16% |
86 | IDYA | IDEAYA Biosciences, Inc. | 0.16% |
87 | JANX | Janux Therapeutics, Inc. | 0.15% |
88 | APGE | Apogee Therapeutics, Inc. | 0.15% |
89 | GRFS | Grifols, S.A. | 0.15% |
90 | IMVT | Immunovant, Inc. | 0.14% |
91 | NAMS | NewAmsterdam Pharma Company N.V. | 0.14% |
92 | n/a | E-MINI HEALTH CARE SECTOR JUN 25 | 0.14% |
93 | VERA | Vera Therapeutics, Inc. | 0.14% |
94 | ALVO | Alvotech | 0.13% |
95 | CGON | CG Oncology, Inc. | 0.13% |
96 | MESO | Mesoblast Limited | 0.13% |
97 | ADPT | Adaptive Biotechnologies Corporation | 0.13% |
98 | ETNB | 89bio, Inc. | 0.13% |
99 | WVE | Wave Life Sciences Ltd. | 0.12% |
100 | SNDX | Syndax Pharmaceuticals, Inc. | 0.12% |
101 | NVAX | Novavax, Inc. | 0.12% |
102 | STVN | Stevanato Group S.p.A. | 0.12% |
103 | IRON | Disc Medicine, Inc. | 0.12% |
104 | GERN | Geron Corporation | 0.12% |
105 | TXG | 10x Genomics, Inc. | 0.11% |
106 | AUPH | Aurinia Pharmaceuticals Inc. | 0.11% |
107 | DYN | Dyne Therapeutics, Inc. | 0.11% |
108 | CDNA | CareDx, Inc | 0.10% |
109 | NRIX | Nurix Therapeutics, Inc. | 0.10% |
110 | IOVA | Iovance Biotherapeutics, Inc. | 0.10% |
111 | SYRE | Spyre Therapeutics, Inc. | 0.10% |
112 | IMCR | Immunocore Holdings plc | 0.10% |
113 | NTLA | Intellia Therapeutics, Inc. | 0.09% |
114 | MYGN | Myriad Genetics, Inc. | 0.09% |
115 | CNTA | Centessa Pharmaceuticals plc | 0.09% |
116 | XNCR | Xencor, Inc. | 0.09% |
117 | GLPG | Galapagos NV | 0.09% |
118 | GRAL | GRAIL, Inc. | 0.09% |
119 | ZYME | Zymeworks Inc. | 0.09% |
120 | RCKT | Rocket Pharmaceuticals, Inc. | 0.09% |
121 | n/a | RUSSELL 2000 EMINI CME JUN 25 | 0.09% |
122 | EVO | Evotec SE | 0.09% |
123 | AVXL | Anavex Life Sciences Corp. | 0.09% |
124 | GPCR | Structure Therapeutics Inc. | 0.08% |
125 | FTRE | Fortrea Holdings Inc. | 0.08% |
126 | COGT | Cogent Biosciences, Inc. | 0.07% |
127 | REPL | Replimune Group, Inc. | 0.07% |
128 | ELVN | Enliven Therapeutics, Inc. | 0.07% |
129 | QURE | uniQure N.V. | 0.07% |
130 | CRMD | CorMedix Inc. | 0.07% |
131 | PRAX | Praxis Precision Medicines, Inc. | 0.07% |
132 | SPRY | ARS Pharmaceuticals, Inc. | 0.07% |
133 | DAWN | Day One Biopharmaceuticals, Inc. | 0.06% |
134 | VIR | Vir Biotechnology, Inc. | 0.06% |
135 | LENZ | LENZ Therapeutics, Inc. | 0.06% |
136 | CSTL | Castle Biosciences, Inc. | 0.06% |
137 | KURA | Kura Oncology, Inc. | 0.06% |
138 | OPK | OPKO Health, Inc. | 0.06% |
139 | ABCL | AbCellera Biologics Inc. | 0.06% |
140 | PRTA | Prothena Corporation plc | 0.06% |
141 | ARVN | Arvinas, Inc. | 0.06% |
142 | RCUS | Arcus Biosciences, Inc. | 0.06% |
143 | CTKB | Cytek Biosciences, Inc. | 0.05% |
144 | ANAB | AnaptysBio, Inc. | 0.05% |
145 | ABUS | Arbutus Biopharma Corporation | 0.05% |
146 | KALV | KalVista Pharmaceuticals, Inc. | 0.05% |
147 | ALT | Altimmune, Inc. | 0.05% |
148 | SAGE | Sage Therapeutics, Inc. | 0.05% |
149 | LAB | Standard BioTools Inc. | 0.05% |
150 | NUVB | Nuvation Bio Inc. | 0.05% |
151 | TBPH | Theravance Biopharma, Inc. | 0.05% |
152 | URGN | UroGen Pharma Ltd. | 0.05% |
153 | ZVRA | Zevra Therapeutics, Inc. | 0.05% |
154 | MLYS | Mineralys Therapeutics, Inc. | 0.04% |
155 | MGTX | MeiraGTx Holdings plc | 0.04% |
156 | RLAY | Relay Therapeutics, Inc. | 0.04% |
157 | AVBP | ArriVent BioPharma, Inc. | 0.04% |
158 | KROS | Keros Therapeutics, Inc. | 0.04% |
159 | RGNX | REGENXBIO Inc. | 0.04% |
160 | VERV | Verve Therapeutics, Inc. | 0.04% |
161 | ORKA | Oruka Therapeutics, Inc. | 0.04% |
162 | HUMA | Humacyte, Inc. | 0.04% |
163 | RIGL | Rigel Pharmaceuticals, Inc. | 0.04% |
164 | TRVI | Trevi Therapeutics, Inc. | 0.04% |
165 | XTSLA | BlackRock Cash Funds Treasury SL Agency | 0.04% |
166 | FLGT | Fulgent Genetics, Inc. | 0.04% |
167 | TYRA | Tyra Biosciences, Inc. | 0.04% |
168 | AURA | Aura Biosciences, Inc. | 0.04% |
169 | STOK | Stoke Therapeutics, Inc. | 0.04% |
170 | PACB | Pacific Biosciences of California, Inc. | 0.03% |
171 | ARCT | Arcturus Therapeutics Holdings Inc. | 0.03% |
172 | CGEM | Cullinan Therapeutics, Inc. | 0.03% |
173 | EBS | Emergent BioSolutions Inc. | 0.03% |
174 | ORIC | ORIC Pharmaceuticals, Inc. | 0.03% |
175 | MXCT | MaxCyte, Inc. | 0.03% |
176 | ATXS | Astria Therapeutics, Inc. | 0.03% |
177 | PGEN | Precigen, Inc. | 0.03% |
178 | SANA | Sana Biotechnology, Inc. | 0.03% |
179 | AUTL | Autolus Therapeutics plc | 0.03% |
180 | ABSI | Absci Corporation | 0.03% |
181 | TRML | Tourmaline Bio, Inc. | 0.03% |
182 | SLDB | Solid Biosciences Inc. | 0.03% |
183 | CVAC | CureVac N.V. | 0.03% |
184 | DNA | Ginkgo Bioworks Holdings, Inc. | 0.03% |
185 | BCYC | Bicycle Therapeutics plc | 0.03% |
186 | MRVI | Maravai LifeSciences Holdings, Inc. | 0.03% |
187 | GLUE | Monte Rosa Therapeutics, Inc. | 0.03% |
188 | VNDA | Vanda Pharmaceuticals Inc. | 0.03% |
189 | TSHA | Taysha Gene Therapies, Inc. | 0.03% |
190 | ERAS | Erasca, Inc. | 0.03% |
191 | SVRA | Savara Inc. | 0.03% |
192 | NGNE | Neurogene Inc. | 0.03% |
193 | QTRX | Quanterix Corporation | 0.03% |
194 | PHAT | Phathom Pharmaceuticals, Inc. | 0.03% |
195 | AVIR | Atea Pharmaceuticals, Inc. | 0.03% |
196 | TSVT | 2seventy bio, Inc. | 0.02% |
197 | TRDA | Entrada Therapeutics, Inc. | 0.02% |
198 | OLMA | Olema Pharmaceuticals, Inc. | 0.02% |
199 | AMLX | Amylyx Pharmaceuticals, Inc. | 0.02% |
200 | ANNX | Annexon, Inc. | 0.02% |
201 | IRWD | Ironwood Pharmaceuticals, Inc. | 0.02% |
202 | ALLO | Allogene Therapeutics, Inc. | 0.02% |
203 | ITOS | iTeos Therapeutics, Inc. | 0.02% |
204 | TERN | Terns Pharmaceuticals, Inc. | 0.02% |
205 | IBRX | ImmunityBio, Inc. | 0.02% |
206 | CDXS | Codexis, Inc. | 0.02% |
207 | CRVS | Corvus Pharmaceuticals, Inc. | 0.02% |
208 | SLRN | Acelyrin, Inc. | 0.02% |
209 | CMPS | COMPASS Pathways plc | 0.02% |
210 | IMMP | Immutep Limited | 0.02% |
211 | TECX | Tectonic Therapeutic, Inc. | 0.02% |
212 | YMAB | Y-mAbs Therapeutics, Inc. | 0.02% |
213 | VYGR | Voyager Therapeutics, Inc. | 0.02% |
214 | RAPP | Rapport Therapeutics, Inc. | 0.02% |
215 | FDMT | 4D Molecular Therapeutics, Inc. | 0.02% |
216 | DSGN | Design Therapeutics, Inc. | 0.02% |
217 | NEO: CYBN | Cybin Inc. | 0.02% |
218 | INBX | Inhibrx Biosciences, Inc. | 0.02% |
219 | RNAC | Cartesian Therapeutics, Inc. | 0.01% |
220 | n/a | CASH COLLATERAL USD SGAFT | 0.01% |
221 | ACIU | AC Immune SA | 0.01% |
222 | PSNL | Personalis, Inc. | 0.01% |
223 | ENTA | Enanta Pharmaceuticals, Inc. | 0.01% |
224 | CRGX | CARGO Therapeutics, Inc. | 0.01% |
225 | CATX | Perspective Therapeutics, Inc. | 0.01% |
226 | CCCC | C4 Therapeutics, Inc. | 0.01% |
227 | MGNX | MacroGenics, Inc. | 0.01% |
228 | ACRV | Acrivon Therapeutics, Inc. | 0.01% |
229 | ADCT | ADC Therapeutics SA | 0.01% |
230 | FHTX | Foghorn Therapeutics Inc. | 0.01% |
231 | PRME | Prime Medicine, Inc. | 0.01% |
232 | ALEC | Alector, Inc. | 0.01% |
233 | EDIT | Editas Medicine, Inc. | 0.01% |
234 | TNGX | Tango Therapeutics, Inc. | 0.01% |
235 | SLN | Silence Therapeutics plc | 0.01% |
236 | ALMS | Alumis Inc. | 0.01% |
237 | FATE | Fate Therapeutics, Inc. | 0.01% |
238 | LRMR | Larimar Therapeutics, Inc. | 0.01% |
239 | PLRX | Pliant Therapeutics, Inc. | 0.01% |
240 | BMEA | Biomea Fusion, Inc. | 0.01% |
241 | THRD | Third Harmonic Bio, Inc. | 0.01% |
242 | LYEL | Lyell Immunopharma, Inc. | 0.01% |
243 | CLYM | Climb Bio, Inc. | 0.01% |
244 | LXEO | Lexeo Therapeutics, Inc. | 0.01% |
245 | TKNO | Alpha Teknova, Inc. | 0.01% |
246 | TCRX | TScan Therapeutics, Inc. | 0.01% |
247 | NMRA | Neumora Therapeutics, Inc. | 0.01% |
248 | NKTX | Nkarta, Inc. | 0.01% |
249 | STRO | Sutro Biopharma, Inc. | 0.01% |
250 | APLT | Applied Therapeutics, Inc. | 0.01% |
251 | PEPG | PepGen Inc. | 0.01% |
252 | KYTX | Kyverna Therapeutics, Inc. | 0.01% |
253 | ARTV | Artiva Biotherapeutics, Inc. | 0.01% |
254 | PYXS | Pyxis Oncology, Inc. | 0.00% |
255 | OKUR | OnKure Therapeutics, Inc. | 0.00% |
256 | n/a | Chinook Therapeutics Inc | 0.00% |
257 | INZY | Inozyme Pharma, Inc. | 0.00% |
258 | MRSN | Mersana Therapeutics, Inc. | 0.00% |
259 | TVGN | Tevogen Bio Holdings Inc. | 0.00% |
260 | IGMS | IGM Biosciences, Inc. | 0.00% |
261 | QTTB | Q32 Bio Inc. | 0.00% |
262 | n/a | Cartesian Therapeutics ([Wts/Rts]) 0% | 0.00% |
263 | n/a | Fusion Pharmaceuticals Inc Cvr | 0.00% |
264 | n/a | Akouos Cvrs Prvt | 0.00% |
265 | n/a | OMNIAB INC $15.00 VESTING Prvt | 0.00% |
266 | n/a | OMNIAB INC $12.50 VESTING Prvt | 0.00% |
267 | n/a | Cash Offset | -0.23% |
As of Mar 21, 2025